University of Pennsylvania: Opioid-Related Disorders trials

The registry lists 34 Opioid-Related Disorders studies with University of Pennsylvania as lead sponsor. 9 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 1 2Phase 2 10Phase 3 6Phase 4 3No phase 17(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Peer Recovery Support for Opioid Use Disorder Treatment RetentionEnrolling by invitationNCT07620171Not applicable
• Adapting the Penny Chatbot for Perinatal OUD Patients: COPILOTRecruitingNCT06969261Not applicable
• Teaching Health Resilience in a Hospital Setting: A Peer-led InterventionRecruitingNCT06843213Not applicable
• Psilocybin on Brain Mechanisms of Motivation in OUDRecruitingNCT06810310Phase 2
• Autobiographical Memory in Opioid Use DisorderRecruitingNCT06643988Not applicable
• An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)RecruitingNCT06576323Not applicable
• Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl UseRecruitingNCT06379984Phase 2
• Improving Access to Opioid Use Disorder Treatment Among Marginalized Patients With a Tailored Telehealth InterventionNot yet recruitingNCT06341608Not applicable
• Integrating Brain, Neurocognitive, and Computational Tools in OUDRecruitingNCT06136247
• User Acceptability of a Device-Based Opioid Overdose InterventionCompletedNCT04530591Results posted
• Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1TerminatedNCT04480554Phase 2Results posted
• Brain Mechanisms of Pharmacotherapy in Opioid Use DisorderTerminatedNCT04454411Phase 2Results posted
• Rapid Initiation of Drug Treatment EngagementCompletedNCT03908437Phase 4Results posted
• Remote Observed Dosing of Suboxone to Improve Clinical PracticeCompletedNCT03769025Phase 1/2Results posted
• The Life STORRIED StudyCompletedNCT03134092Not applicableResults posted
• Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable NaltrexoneCompletedNCT02617628Phase 2/3Results posted
• Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt SiteCompletedNCT00781898Phase 2/3Results posted
• Addiction Treatment in Russia: Oral vs. Naltrexone ImplantCompletedNCT00218426Phase 2/3Results posted
• Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment EngagementActive, not recruitingNCT05897788Not applicable
• Tau PET Imaging in Opioid Use DisorderCompletedNCT05651516Early Phase 1
• Improving Insomnia in Patients With Opioid Use DisorderWithdrawnNCT05588726Not applicable
• Multi-System Analysis of Opioid Receptor BindingActive, not recruitingNCT05528848Phase 1
• Medication-assisted Treatment for Injecting Drug Users in VietnamCompletedNCT05368675Phase 4
• Increasing Implementation of Post-Operative Opioid Prescribing GuidelinesCompletedNCT05358522Not applicable
• Olanzapine in OUD PatientsWithdrawnNCT05179772Phase 2
• Distribution of Medication Disposal Packets - Acute Opioid PrescribingCompletedNCT05169281Not applicable
• The Whole Health Study: Collaborative Care for OUD and Mental Health ConditionsCompletedNCT04245423Not applicable
• Opioid Analgesic Use and Disposal Following Outpatient Dental SurgeryCompletedNCT02814305Not applicable
• Biomarkers of Injectable Extended Release Naltrexone TreatmentCompletedNCT02324725Phase 4
• Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release NaltrexoneCompletedNCT01882361Phase 2/3
• Remote Observed Dosing to Increase Suboxone ComplianceCompletedNCT01779973Not applicable
• Depot Naltrexone Treatment of Opioid Dependent ParoleesCompletedNCT00756990Not applicable
• Methadone Maintenance & HIV Risk in UkraineCompletedNCT00351026Phase 3
• Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1CompletedNCT00078130Phase 3